Skip to main content
. 2020 Oct 21;64(6):654–663. doi: 10.20945/2359-3997000000300

Table 1. Relevant articles founded with the Boolean logic algorithm in the PubMed platform.

Clinicaldata Sample type Analytical tool Cohort Pathways Ref
To compare the serum metabolome between GHD patients and healthy controls, and identification of potential markers for diagnosis and/or for individual GH dosing Serum GC-MS 10 Lipid and protein metabolism [( 26 )]
A 17 year old female adolescent with severe GHD secondary to PIT-1 gene mutation. The subject was subsequently followed for 5 years with and without GH therapy Urine NMR 1 Beta-oxidation; TCA cycle [( 27 )]
All patients with short stature were confirmed to be due to the endocrine disorders, especially GH deficiency (GHD) Serum NMR 45 Glucose; amino acids [( 59 )]

GC-MS: gas chromatography mass spectrometry; NMR: nuclear magnetic resonance; TCA cycle: tricarboxylic acid cycle or Krebs cycle.